Funding
breakthrough
technologies that will
“disrupt” climate change

Nucleation Capital is climate solution-focused venture capital fund that has been designed to make venture investing easier and more affordable for more individual investors.  We are investing in early and mid-stage ventures primarily developing zero-emission nuclear energy and carbon-negative technologies to enable the world’s transition to a 100% carbon-free economy and, ultimately, to achieve a net carbon-negative economy.  Our target geographies are the U.S., Canada, and the U.K. but we may make exceptions for English-speaking companies located outside these primary regions.

Our focus is on those ventures developing technologies most likely to succeed in addressing the growing global demand for carbon-free energy—reducing climate threats while improving grid reliability. In as much as climate change is a global crisis, those helping to solve the crisis by disrupting fossil fuels use and the “business-as-usual” economy have the potential for realizing outsized returns.

We look for entrepreneurial teams making rapid progress developing and commercializing competitive innovations, leveraging public and private capital, and building the partnerships and customer relationships needed to accelerate deployments of technologies with the greatest potential for gigaton-scale reductions in emissions.  Our top areas of interest are: 

1


Advanced Nuclear
ventures developing state-of-the-art reactors for reliable, carbon-free and low-impact energy for grid-based and off-grid electricity generation and industrial heat applications, as well as a wide array of supporting ventures (such as supply chain, advanced fuels and materials, advanced manufacturing and robotics, software control systems, waste storage, waste treatment, deployment, operations training, and so on).

2


Deep Decarbonization
ventures which broadly consist of carbon capture, utilization and sequestration (CCUS) but which can include direct air capture, development of synthetic fuels, chemicals, fertilizers, foods or recombinations of energy designed to help accelerate decarbonization, such as hydrogen production.

3


Grid Optimization
ventures which accelerate smarter grids and advanced grid integrations enabling these critical systems to better manage and balance growing demand, distributed generation, demand pricing and energy routing in more sophisticated ways and under an increasing range of environmental stresses and energy demands.

Want more confirmation?
Click the link to listen to President Biden’s Secretary of Energy, Jennifer Granholm, talking about the need for advanced nuclear and carbon capture.

Are you ready to try something different?
Re-allocate your traditional fossil funds
into future clean technologies!

There’s finally a way

Qualified and accredited investors now have the ability to participate in Nucleation Capital’s climatetech fund or syndication in a way that lets each investor select the terms that work for them.

Nucleation uses an investment platform that allows us to set lower minimums. This means any qualified investor (based anywhere in the world) can apply online to gain access to these exciting areas of climate innovation and participate with smaller investments that make venture investing accessible.

If you are looking to build a diversified portfolio, we recommend you subscribe to our venture fund. You select the level of your subscription and the number of quarters that you wish to participate for and you’ll get a pro rata share of all of the ventures that we invest in for each of those quarters. If you would like to learn about select equity opportunities and be able to evaluate whether or not to invest in individual offerings, you can join our syndication network. As a subscriber to our fund, you will get discounted fees in our syndications.

For most of its history, governments funded nuclear innovation. But now, private ventures are racing to commercialize next generation innovations, attracting investors like Bill Gates, Jeff Bezos, and Peter Thiel. Yet, participation in this sector remained out of reach for most accredited investors. Nucleation Capital seeks to change that paradigm, making participation affordable to more investors.

Why aren’t you investing according to your values?

Albert Einstein defined insanity as “Doing the same thing over and over again and expecting different results.”  We have yet to “bend the curve” on our fossil fuel emissions. Maybe it is time to make a change in how you invest!    

Investing with Nucleation Capital

We invite you to invest in the advanced energy technologies best suited to enable the transition away from carbon-emitting energies. Like all venture funds, Nucleation Capital will be investing primarily in early-stage, pre-revenue ventures with a high risk of failure. Such ventures take time to grow and build value and can remain illiquid for many years. Thus, you should be able to provide “patient capital,” and only invest an amount that you can afford to risk the full loss of principal. Fortunately, our subscription model allows you to select an investment level that best suits you, your portfolio and your risk tolerance. You can now participate in our venture fund with a subscription starting as low as $5,000 per quarter or in our syndicated offerings in amounts starting as low as $1,000.

If interested, we will send more information

1

Click the button below button to answer some questions and indicate which of our investment services interests you. 

2

We will get back to you quickly with the appropriate information, including links to access our investor presentation, terms, legal documents and online subscription process.

3

If you indicate that you’d like for us to contact you, we will also be in touch with you about scheduling a meeting. 

Note:  The U.S. Securities and Exchange Commission (SEC) requires that investors participating in offerings of unregistered securities, such as those offered by Nucleation Capital, be  accredited investors. We cannot accept investments from non-accredited individuals.